Richard Stephens

Title: Richard Stephens: Innovator in Immunology

Introduction

Richard Stephens is a notable inventor based in Oakland, CA (US). He has made significant contributions to the field of immunology, particularly in the development of immunoassays for detecting chlamydial antigens and antibodies. With a total of 3 patents, his work has had a lasting impact on medical diagnostics.

Latest Patents

Stephens' latest patents include innovative methods and compositions for producing polypeptides that are immunologically cross-reactive with the major outer membrane protein (MOMP) of Chlamydia trachomatis. One of his patents describes a DNA construct that includes a replication system recognized by E. coli, along with an MOMP gene under the transcriptional control of a beta-galactosidase promoter and terminator. Notably, recombinant phage λgt11/L2/33 was deposited at the American Type Culture Collection on January 10, 1985, and granted accession number 40157. Additionally, L2 B9-F DNA was deposited at the same institution on December 31, 1985, and granted accession number 40217.

Career Highlights

Throughout his career, Richard Stephens has worked with prominent organizations such as the Washington Research Foundation and Chiron Corporation. His expertise in immunology has allowed him to contribute to various research projects and advancements in the field.

Collaborations

Some of his notable coworkers include Nina Agabian and Cho-chou Kuo. Their collaborative efforts have furthered research in immunology and diagnostics.

Conclusion

Richard Stephens is a distinguished inventor whose work in immunology has led to significant advancements in medical diagnostics. His contributions continue to influence the field and improve healthcare outcomes.